When the world gets closer.

We help you see farther.

Sign up to our expressly international daily newsletter.

Already a subscriber? Log in.

You've reach your limit of free articles.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Ad-free experience NEW

Exclusive international news coverage

Access to Worldcrunch archives

Monthly Access

30-day free trial, then $2.90 per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch
Sources

New Zealand May Become First Country To OK Sale Of Psychoactive "Party Pills"

AAP (Australia); NZ HERALD, RADIO NEW ZEALAND, SCOOP (New Zealand)

Worldcrunch

WELLINGTON - Parliament on Tuesday approved a measure that would make New Zealand the first country to legalize synthetic drugs, otherwise known as party pills. If it gains final approval later this year, the Psychoactive Substances Bill would create a system to test and approval certain mind-altering drugs.

This bill, reports the Scoop Media website, would allow for the sale and consumption of synthetic drugs that have been proven to be safe and meet manufacturing requirements. Prison sentences of eight years will be imposed on those selling drugs that are not legally approved.

Radio New Zealand says this will apply to all products that contain psychoactive material -- excluding alcohol or tobacco -- or those covered in the country's Misuse of Drugs Act.

The application fee for the clinical trials for all companies seeking approval of their products will cost more than $150,000, and testing could run up to $1.7 million, says the NZ Herald.

Associate Health Minister Peter Dunne said in March that most countries have tried prohibiting synthetic highs, but soon all faced the same problem of new variations quickly returning to the market, reports the AAP. "There is a game of cat and mouse where an irresponsible industry seeks to elude authorities and circumvent the law by bringing new chemicals to a lucrative market."

New Zealand Drug Foundation executive director Ross Bell called for a ban on advertising, as well as requirements of “unsexy packaging.” He said that plain packaging should be introduced as part of the legislation to prevent legal battles with the industry in the future.

In order to prove that these drugs are safe, they must be tested. Dunne says whether it will be on animals or not was still to be decided, according to the Herald. He did, however, rule out “the controversial” lethal dose 50% (LD50) test, where increasing doses of a tested drug are given to a sample group of animals until half of them die.

A final vote on the legislation is slated for August.

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

FOCUS: Russia-Ukraine War

A First Look At Russia's Ukraine War Veterans, Struggling Back On The Homefront

Hundreds of thousands of Russians have taken part in the war. On returning, many face difficulties to return to normal life and finding work, as independent Russian news outlet Vazhnyye Istorii/Important Stories reports.

Image of a Man waiting in line at Military Employment Office of the Russian Armed Forces​

Man waiting in line at an employment office in Moscow

РЕДАКЦИЯ

MOSCOW — Since the beginning of the full-scale invasion of Ukraine, hundreds of thousands of Russians have taken part in the war. They range from professional soldiers, National Guardsmen, reservists and conscripts to mercenaries of illegal armed groups, including former prisoners.

The exact number of those who survived and returned home is unknown. In the past year alone, about 50,000 citizens received the status “combat veteran”. The actual number of returnees from the front is far higher, but it is often extremely difficult to obtain veteran status and veteran benefits.

Keep reading...Show less

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Already a subscriber? Log in.

You've reach your limit of free articles.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Ad-free experience NEW

Exclusive international news coverage

Access to Worldcrunch archives

Monthly Access

30-day free trial, then $2.90 per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch

The latest